GENEVA, July 21 -- INTRABIO INC. (201 W 5th StreetSuite 1100Austin, Texas 78701) filed a patent application (PCT/US2025/010860) for "N-ACETYL-LEUCINE FOR USE IN THE TREATMENT OF PRODROMAL ALPHA-SYNUCLEINOPATHIES" on Jan 09, 2025. With publication no. WO/2025/151578, the details related to the patent application was published on Jul 17, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): STRUPP, Michael (University Hospital MunichCampus Grosshadern, Marchioninistr. 1581377 Munich), FACTOR, Mallory (27 Linton RoadOxfordOxfordshire Oxfordshire OX2 6UL)
Abstract:
The present disclosure provides f...